1	Cobalt	Cobalt	_	_	_	_	_	_	_
2	chloride-induced	chloride-induced	_	_	_	_	_	_	_
3	signaling	signaling	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	endothelium	endothelium	_	_	_	_	_	_	_
6	leading	lead	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	augmented	augmented	_	_	_	_	_	_	_
10	adherence	adherence	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	sickle	sickle	_	_	_	_	_	_	_
13	red	red	_	_	_	_	_	_	_
14	blood	blood	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	transendothelial	transendothelial	_	_	_	_	_	_	_
18	migration	migration	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	monocyte-like	monocyte-like	_	_	_	_	_	_	_
21	HL-60	hl-60	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	is	be	_	_	_	_	_	_	_
24	blocked	block	_	_	_	_	_	_	_
25	by	by	_	_	_	_	_	_	_
26	PAF-receptor	PAF-receptor	_	_	_	_	_	_	_
27	antagonist	antagonist	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	response	response	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	hypoxia	hypoxia	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	sickle	sickle	_	_	_	_	_	_	_
7	red	red	_	_	_	_	_	_	_
8	blood	blood	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	SS	SS	_	_	_	_	_	_	_
12	RBC	RBC	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	leukocytes	leukocyte	_	_	_	_	_	_	_
16	exhibit	exhibit	_	_	_	_	_	_	_
17	increased	increase	_	_	_	_	_	_	_
18	adherence	adherence	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	vascular	vascular	_	_	_	_	_	_	_
22	endothelium	endothelium	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	while	while	_	_	_	_	_	_	_
25	diapedesis	diapedesis	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	leukocytes	leukocyte	_	_	_	_	_	_	_
28	through	through	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	blood	blood	_	_	_	_	_	_	_
31	vessel	vessel	_	_	_	_	_	_	_
32	increases	increase	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	cellular	cellular	_	_	_	_	_	_	_
5	signaling	signaling	_	_	_	_	_	_	_
6	pathway(s)	pathway(s)	_	_	_	_	_	_	_
7	caused	cause	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	hypoxia	hypoxia	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	poorly	poorly	_	_	_	_	_	_	_
12	understood	understand	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	utilized	utilize	_	_	_	_	_	_	_
3	CoCl2	cocl2	_	_	_	_	_	_	_
4	as	as	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	mimetic	mimetic	_	_	_	_	_	_	_
7	molecule	molecule	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	hypoxia	hypoxia	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	study	study	_	_	_	_	_	_	_
12	cellular	cellular	_	_	_	_	_	_	_
13	signaling	signaling	_	_	_	_	_	_	_
14	pathways	pathway	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	found	find	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	umbilical	umbilical	_	_	_	_	_	_	_
7	vein	vein	_	_	_	_	_	_	_
8	endothelial	endothelial	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	HUVEC	HUVEC	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	CoCl2	cocl2	_	_	_	_	_	_	_
15	at	at	_	_	_	_	_	_	_
16	2	2	_	_	_	_	_	_	_
17	mM	mm	_	_	_	_	_	_	_
18	concentration	concentration	_	_	_	_	_	_	_
19	induced	induce	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	surface	surface	_	_	_	_	_	_	_
22	expression	expression	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	subset	subset	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	CAMs	CAM	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	VCAM-1	VCAM-1	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	activation	activation	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	transcription	transcription	_	_	_	_	_	_	_
35	factor	factor	_	_	_	_	_	_	_
36	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	nuclear	nuclear	_	_	_	_	_	_	_
40	extracts	extract	_	_	_	_	_	_	_
41	of	of	_	_	_	_	_	_	_
42	HUVEC	HUVEC	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	CoCl2	CoCl2	_	_	_	_	_	_	_
4	also	also	_	_	_	_	_	_	_
5	caused	cause	_	_	_	_	_	_	_
6	time-dependent	time-dependent	_	_	_	_	_	_	_
7	tyrosine	tyrosine	_	_	_	_	_	_	_
8	phosphorylation	phosphorylation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	mitogen-activated	mitogen-activated	_	_	_	_	_	_	_
11	protein	protein	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	MAP	MAP	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	kinase	kinase	_	_	_	_	_	_	_
16	isoform	isoform	_	_	_	_	_	_	_
17	ERK2	erk2	_	_	_	_	_	_	_
18	without	without	_	_	_	_	_	_	_
19	significantly	significantly	_	_	_	_	_	_	_
20	affecting	affect	_	_	_	_	_	_	_
21	ERK1	erk1	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	indicating	indicate	_	_	_	_	_	_	_
24	ERK2	erk2	_	_	_	_	_	_	_
25	is	be	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	preferred	prefer	_	_	_	_	_	_	_
28	substrate	substrate	_	_	_	_	_	_	_
29	for	for	_	_	_	_	_	_	_
30	upstream	upstream	_	_	_	_	_	_	_
31	kinase	kinase	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	MAPK	MAPK	_	_	_	_	_	_	_
35	pathway	pathway	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Inhibitors	inhibitor	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	MAP	MAP	_	_	_	_	_	_	_
4	kinase	kinase	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	PD98059	PD98059	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	platelet-activating	platelet-activating	_	_	_	_	_	_	_
10	factor	factor	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	PAF)-	paf)-	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	antagonist	antagonist	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	CV3988	cv3988	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	inhibited	inhibit	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	CoCl2-induced	cocl2-induced	_	_	_	_	_	_	_
21	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
22	activation	activation	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	VCAM-1	vcam-1	_	_	_	_	_	_	_
25	expression	expression	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Augmented	augmented	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	VCAM-1	vcam-1	_	_	_	_	_	_	_
5	led	lead	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	increased	increase	_	_	_	_	_	_	_
8	SS	SS	_	_	_	_	_	_	_
9	RBC	RBC	_	_	_	_	_	_	_
10	adhesion	adhesion	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	inhibitable	inhibitable	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	VCAM-1	vcam-1	_	_	_	_	_	_	_
16	antibody	antibody	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Additionally	additionally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	CoCl2	CoCl2	_	_	_	_	_	_	_
4	caused	cause	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	two-	two-	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	threefold	threefold	_	_	_	_	_	_	_
9	increase	increase	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	rate	rate	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	transendothelial	transendothelial	_	_	_	_	_	_	_
15	migration	migration	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	monocyte-like	monocyte-like	_	_	_	_	_	_	_
18	HL-60	hl-60	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	twentyfold	twentyfold	_	_	_	_	_	_	_
23	increase	increase	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	phosphorylation	phosphorylation	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	platelet	platelet	_	_	_	_	_	_	_
28	endothelial	endothelial	_	_	_	_	_	_	_
29	cell	cell	_	_	_	_	_	_	_
30	adhesion	adhesion	_	_	_	_	_	_	_
31	molecules	molecule	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	PECAM-1	pecam-1	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transendothelial	transendothelial	_	_	_	_	_	_	_
3	migration	migration	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	monocytes	monocyte	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	inhibited	inhibit	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	antibody	antibody	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	PECAM-1	pecam-1	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	phosphorylation	phosphorylation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	PECAM-1	pecam-1	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	transendothelial	transendothelial	_	_	_	_	_	_	_
7	migration	migration	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	monocytes	monocyte	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	response	response	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	CoCl2	CoCl2	_	_	_	_	_	_	_
14	were	be	_	_	_	_	_	_	_
15	inhibited	inhibit	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	protein	protein	_	_	_	_	_	_	_
18	kinase	kinase	_	_	_	_	_	_	_
19	inhibitor	inhibitor	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	GF109203X	GF109203X	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	augmented	augment	_	_	_	_	_	_	_
25	by	by	_	_	_	_	_	_	_
26	protein	protein	_	_	_	_	_	_	_
27	phosphatase	phosphatase	_	_	_	_	_	_	_
28	inhibitor	inhibitor	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	Calyculin	Calyculin	_	_	_	_	_	_	_
31	A	A	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	suggests	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	CoCl2-induced	cocl2-induced	_	_	_	_	_	_	_
6	cellular	cellular	_	_	_	_	_	_	_
7	signals	signal	_	_	_	_	_	_	_
8	directing	direct	_	_	_	_	_	_	_
9	increased	increase	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	VCAM-1	vcam-1	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	HUVEC	HUVEC	_	_	_	_	_	_	_
15	involve	involve	_	_	_	_	_	_	_
16	downstream	downstream	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	MAP	MAP	_	_	_	_	_	_	_
20	kinase	kinase	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	while	while	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	phosphorylation	phosphorylation	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	PECAM-1	pecam-1	_	_	_	_	_	_	_
29	occurs	occur	_	_	_	_	_	_	_
30	as	as	_	_	_	_	_	_	_
31	a	a	_	_	_	_	_	_	_
32	result	result	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	activation	activation	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	PKC	PKC	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	conclude	conclude	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	PAF-receptor	PAF-receptor	_	_	_	_	_	_	_
5	antagonist	antagonist	_	_	_	_	_	_	_
6	inhibits	inhibit	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	CoCl2-	cocl2-	_	_	_	_	_	_	_
9	or	or	_	_	_	_	_	_	_
10	hypoxia-induced	hypoxia-induced	_	_	_	_	_	_	_
11	increase	increase	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	adhesion	adhesion	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	SS	SS	_	_	_	_	_	_	_
17	RBC	RBC	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	PECAM-1	pecam-1	_	_	_	_	_	_	_
20	phosphorylation	phosphorylation	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	concomitant	concomitant	_	_	_	_	_	_	_
25	transendothelial	transendothelial	_	_	_	_	_	_	_
26	migration	migration	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	monocytes	monocyte	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

